Tandem Diabetes Care (TNDM) EBT Margin (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly EBT Margin came in at 8.13% in Q2 2026, up 1585.0% on a YoY basis from 0.48% in Q2 2025, and down 1.02% quarter-over-quarter from 8.05% in Q1 2026.
Powered by 
Analysis
Tandem Diabetes Care (TNDM) EBT Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported EBT Margin for 14 consecutive years, with 8.13% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 1585.0% year-over-year to 8.13%; the trailing twelve-month figure through Jun 2026 stood at 5.86% (up 1435.0% YoY), and the FY2025 full-year result was 19.74%, down 997.0% from the prior year.
- EBT Margin declined to 8.13% in Q2 2026 per TNDM's latest filing, from 8.05% in the prior quarter.
- Across five years, EBT Margin topped out at 1.63% in Q4 2025 and bottomed at 72.97% in Q1 2023.
- Historically, EBT Margin has averaged 17.41% across 5 years, with a median of 11.75% in 2024.
- The sharpest annual moves came in 2023 and 2024: EBT Margin sank 6363 bps in 2023, then surged 5235 bps in 2024.
- Over 5 years, EBT Margin stood at 7.31% in 2022, then plunged by 118 bps to 15.91% in 2023, then soared by 100 bps to 0.01% in 2024, then soared by 15240 bps to 1.63% in 2025, then tumbled by 599 bps to 8.13% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 8.13%, 8.05%, and 1.63% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.71 Bn | 174.10 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.20 Bn | 108.38 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 104.00 Bn | 100.53 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 63.32 Bn | 62.78 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.70 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 32.88 Bn | 31.43 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.27 Bn | 30.33 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.32% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 803.45 Mn | 144.78 Mn | -8.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.13% |
| Mar 31, 2026 | -8.05% |
| Dec 31, 2025 | 1.63% |
| Sep 30, 2025 | -10.09% |
| Jun 30, 2025 | -23.98% |
| Mar 31, 2025 | -52.09% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | -9.27% |
| Jun 30, 2024 | -13.40% |
| Mar 31, 2024 | -20.62% |
| Dec 31, 2023 | -15.91% |
| Sep 30, 2023 | -16.55% |
| Jun 30, 2023 | -17.68% |
| Mar 31, 2023 | -72.97% |
| Dec 31, 2022 | -7.31% |
| Sep 30, 2022 | -23.15% |
| Jun 30, 2022 | -6.49% |
| Mar 31, 2022 | -9.35% |
| Dec 31, 2021 | 5.29% |
| Sep 30, 2021 | 3.26% |